Skip to main content
Toggle navigation
Login
Search
Home
Conference Brochure
Tweets by JADPRO Live 2022
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
CE credit available
Pharmacology credit available
Browse by Poster Title
Browse by Poster Title
Type here to filter the list
All
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
#
Sort by
#
Sort by
Title
S
JL1032E
Stable disease (SD) on amivantamab in post-platinum epidermal growth factor receptor (EGFR) Exon 20 insertion (Exon20ins) mutated non-small cell lung cancer (NSCLC): A response-based analysis
Industry Encore Posters
Favorite
JL1029C
Strategies for Optimization and Growth of an Oncology Symptom Management Advanced Practice Provider–Driven Clinic
Clinical Posters
Favorite
JL1033E
Subcutaneous epcoritamab with rituximab + lenalidomide (R2) in patients (pts) with relapsed or refractory (R/R) follicular lymphoma (FL): update from phase 1/2 trial
Industry Encore Posters
Favorite
JL1034E
SunRISe-1: phase 2b study of TAR-200 in combination with cetrelimab, TAR-200 alone, or cetrelimab alone in participants with high-risk non-muscle-invasive bladder cancer unresponsive to intravesical bacillus Calmette-Guérin who are ineligible for or elected not to undergo radical cystectomy
Industry Encore Posters
Favorite
